Prednisolone Acetate + GatifloxacinThird Party Manufacturing in India

Prednisolone Acetate + Gatifloxacin Eye Drops combine a potent corticosteroid with a broad-spectrum fluoroquinolone antibiotic to provide dual anti-inflammatory and antimicrobial action.

Prednisolone acetate works by binding to glucocorticoid receptors in ocular tissues, activating anti-inflammatory gene transcription while suppressing pro-inflammatory mediators. It inhibits phospholipase A2, preventing the release of arachidonic acid and thereby blocking the synthesis of prostaglandins, leukotrienes, and other inflammatory cytokines. This results in rapid reduction of ocular edema, redness, and cellular infiltration.

Gatifloxacin, a fourth-generation fluoroquinolone, exerts its bactericidal effect by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV — two essential enzymes required for bacterial DNA replication, transcription, and repair. This dual-target mechanism makes gatifloxacin highly effective against a wide range of Gram-positive and Gram-negative ocular pathogens, including Staphylococcus aureus, Streptococcus pneumoniae, and Pseudomonas aeruginosa.

The combination ensures that while prednisolone suppresses the host inflammatory response, gatifloxacin simultaneously targets any concurrent or opportunistic bacterial infection — a critical advantage in post-surgical and traumatic eye conditions.

Therapeutic Uses

Prednisolone Acetate + Gatifloxacin Eye Drops are indicated for:

• Post-Operative Inflammation and Infection Prophylaxis: Used after cataract and refractive surgery to prevent both inflammation and bacterial infection in one bottle
• Bacterial Conjunctivitis with Severe Inflammation: Treats acute bacterial conjunctivitis where significant inflammatory response is present
• Post-Traumatic Ocular Inflammation: Manages inflammation while preventing secondary bacterial infection in corneal abrasions and foreign body injuries
• Blepharoconjunctivitis: Controls eyelid margin inflammation with associated bacterial involvement
• Keratitis with Bacterial Risk: Provides coverage for superficial keratitis where bacterial superinfection is a concern

Why Manufacturers Choose This Combination

The corticosteroid-fluoroquinolone fixed-dose combination is a staple in ophthalmic surgery protocols worldwide. By combining both active ingredients in a single bottle, it improves patient compliance and reduces the need for multiple drops. This combination is in high demand for cataract surgery aftercare, which is one of the most commonly performed surgeries globally.

Indian ophthalmic manufacturers with WHO-GMP certified facilities are well-positioned to produce this combination for domestic hospitals and export markets. The product is a priority for PCD franchise distributors and third party manufacturing in India due to its high prescription volume and preference among ophthalmologists for post-operative care.